GLP-1 medications work by mimicking glucagon-like peptide-1, a hormone released from the gut after eating, which regulates blood sugars and appetite
Metformin remains the first-line pharmacological approach to the treatment of T2DM, along with lifestyle modification, with the exception of cases where metformin is not tolerated or contraindicated
News2 weeks ago New menopause drug approved for use by NHS in Scotland Hormonal health1 week ago Stardust period tracker shares health data, study reveals News4 days ago Zero Candida market set to reach over US$2 billion by 2030 report News1 week ago Womens health draws record $1.55bn in equity as capital spreads beyond the mega-rounds Insight2 weeks ago Softening ovaries could extend fertility as women age, study suggests Entrepreneur1 week ago Onto Health acquires diagnostics software company Levy Health News1 week ago Congress urged to invest over $20bn to close womens health gap Menopause1 week ago Many women still confused about perimenopause, research finds
The coding sequence of the SmGST gene was cloned into the prokaryotic expression vector pQE-80L, and BL21 bacteria harboring the recombinant plasmid pQE-80L-SmGST expressed a soluble fusion protein
Most patients report feeling the medication's effects most clearly about two to three days after their weekly injection
